Join us for the session “DNA Repair and Immunosurveillance” at #EACR2025, where I’ll be giving a talk on neutrophils and synthetic lethality in breast cancer”
17.06.2025 14:59 — 👍 4 🔁 0 💬 0 📌 0
Getting ready to start!
Join us for this session #AACR2025 where I will be speaking alongside Nicky McGranahan and Ronny Drapkin.
Looking forward to an exciting discussion on how immunology shapes cancer initiation!
1:00 p.m. - 2:30 p.m. — see you there!
27.04.2025 16:55 — 👍 1 🔁 0 💬 0 📌 0
Thrilled to share that our group will be presenting at a major symposium at the AACR Annual Meeting in Chicago this Sunday!
Catch us at AACR—Chicago, we’re ready!
#AACR25 #CancerResearch #Immunology #SomaticEvolution #EarlyDetection #CancerBiology #TeamScience #SeeYouInChicago
21.04.2025 09:25 — 👍 2 🔁 0 💬 0 📌 0
Bellinzona is ready to host the next SYIS seminar on April 17!
I’m excited to join the event as a speaker, alongside Christian Pasquali from OM Pharma.
Join us at 5:00 pm (CET) — either in person in Bellinzona or online via Zoom!
16.04.2025 20:37 — 👍 3 🔁 0 💬 0 📌 1
Postdoctoral researcher at the Pittet Lab in the Agora Cancer Research Center, Lausanne, Switzerland.
Studying cellular #stress responses, particularly #senescence and its impact on #immune response, #ageing and #cancer, #tumorigenesis at Cancer Research UK CI @cruk-ci.bsky.social, University of Cambridge @cam.ac.uk
Website: naritalab.com
Breast cancer physician scientist. Group Leader, ICR London. Consultant oncologist, the Royal Marsden Hospital. Advancing personalised breast cancer medicine through data integration and AI.
Professor at University of Cambridge Department of Pharmacology and Cambridge Stem Cell Institute. Fellow of Magdalene College.
Ageing, Resilience and Cancer Prevention
www.wtklab.com
Citizen of the world. Scientist dedicated to end cancer suffering. Mechanisms of breast cancer metastasis. Personalized medicine. Mentor.
FGB promotes therapeutic innovation from the earliest phases of research and the education of new generations of physician-scientists in Oncology
Breast cancer biologist, mom, bookworm. Our lab loves hormones, contemporary models of disease, and omics.
Researcher within tumor immunology in the Arvelund lab, Linköping university.
Exploring the role of DC subtypes in oncolytic virus based immunotherapy 👩🏼🔬🦠
Open access journal highlighting new discoveries, technical developments and policies in basic, translational, and clinical cancer research. Part of FEBS Press.
moloncol.org
Institute of Oncology Research. President, ICML Local Organizing Committee. USI. Personal opinions only. #lymsm #lymphoma
Staff scientist at Institute of Oncology Research, Bellinzona.
We study how micro-environmental and epigenetic mechanisms drive cancer cells into dormancy. We seek to control this biology to prevent and treat metastasis. https://einsteinmed.edu/faculty/16974/julio-aguirre-ghiso
International Open Access journal publishing on molecular and translational medicine. IF 2024,9.4; Scopus Citescore 2024, 8.4.
18th International Conference on Malignant Lymphoma (June 17-21, 2025 - Lugano, Switzerland)
#18ICML
www.icml.ch
Executive Editor/Team Leader Open Access Science Journals Sage Publishing
Opinions = mine
http://linkedin.com/in/jlovick-editor
#oncology #cancerresearch #medicine #biology #cardiology #neurology #microbiology #publichealth #healthcare #technology
Executive Editor of Cancer Discovery, published by AACR. Harvard BBS/Dana-Farber alum. Native New Yorker. Posts are my own. She/her https://aacrjournals.org/cancerdiscovery
PrIISM at Icahn Mount Sinai | powering immunology research from human profiling through mechanistic studies in preclinical models, towards the development & testing of new immunotherapies
Cancer Researcher passionate about Lobular Carcinoma, Preclinical Oncology, Discovery Science & Advocacy @LobularBCA, EACR ECR Council Member @helloeacr.bsky.social
Scientist, Director of ISREC Foundation, mentor and manager, epigenetist
Nature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community.